IBIO
Income statement / Annual
Last year (2024), iBio, Inc.'s total revenue was $225,000.00,
and the percentage change from the previous year is not available.
In 2024, iBio, Inc.'s net income was -$24.91 M.
See iBio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
| Operating Revenue |
$225,000.00 |
$0.00 |
$2.38 M |
$2.37 M |
$1.64 M |
$2.02 M |
$444,000.00 |
$394,000.00 |
$948,000.00 |
$1.85 M |
| Cost of Revenue |
$0.00
|
$1.11 M
|
$216,000.00
|
$1.46 M
|
$703,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$225,000.00
|
-$1.11 M
|
$2.17 M
|
$909,000.00
|
$935,000.00
|
$2.02 M
|
$444,000.00
|
$394,000.00
|
$948,000.00
|
$1.85 M
|
| Gross Profit Ratio |
1
|
0
|
0.91
|
0.38
|
0.57
|
1
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$5.19 M
|
$10.33 M
|
$17.73 M
|
$9.99 M
|
$3.21 M
|
$5.47 M
|
$3.99 M
|
$4.12 M
|
$3.16 M
|
$3.50 M
|
| General & Administrative Expenses |
$11.67 M
|
$19.02 M
|
$34.13 M
|
$22.03 M
|
$12.43 M
|
$12.33 M
|
$10.69 M
|
$10.55 M
|
$7.69 M
|
$5.02 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$11.67 M
|
$19.02 M
|
$34.13 M
|
$22.03 M
|
$12.43 M
|
$12.33 M
|
$10.69 M
|
$10.55 M
|
$7.69 M
|
$5.02 M
|
| Other Expenses |
$0.00
|
$0.00
|
$13,000.00
|
$12,000.00
|
$10,000.00
|
$16,000.00
|
$19,000.00
|
$25,000.00
|
$21,000.00
|
$32,000.00
|
| Operating Expenses |
$16.86 M
|
$29.34 M
|
$51.86 M
|
$32.02 M
|
$15.64 M
|
$17.81 M
|
$14.67 M
|
$14.67 M
|
$10.84 M
|
$8.52 M
|
| Cost And Expenses |
$16.86 M
|
$29.34 M
|
$52.07 M
|
$33.48 M
|
$15.64 M
|
$17.81 M
|
$14.67 M
|
$14.67 M
|
$10.84 M
|
$8.52 M
|
| Interest Income |
$363,000.00
|
$130,000.00
|
$178,000.00
|
$140,000.00
|
$15,000.00
|
$75,000.00
|
$15,000.00
|
$39,000.00
|
$22,000.00
|
$9,000.00
|
| Interest Expense |
$172,000.00
|
$0.00
|
$1.41 M
|
$2.45 M
|
$2.47 M
|
$1.90 M
|
$1.92 M
|
$1.93 M
|
$807,000.00
|
$0.00
|
| Depreciation & Amortization |
$1.25 M
|
$1.11 M
|
$3.79 M
|
$2.41 M
|
$2.24 M
|
$1.75 M
|
$1.71 M
|
$1.68 M
|
$940,000.00
|
$363,000.00
|
| EBITDA |
-$14.02 M |
-$28.12 M |
-$25.72 M |
-$18.35 M |
-$11.74 M |
-$13.95 M |
-$12.48 M |
-$12.53 M |
-$8.91 M |
-$6.30 M |
| EBITDA Ratio |
-62.32
|
0
|
-19.18
|
-13.06
|
-7.17
|
-6.91
|
-28.12
|
-31.81
|
-9.4
|
-3.41
|
| Operating Income Ratio |
-73.93
|
0
|
-20.85
|
-13.12
|
-8.55
|
-7.82
|
-32.04
|
-36.23
|
-10.44
|
-3.6
|
| Total Other Income/Expenses Net |
$1.19 M
|
$0.00
|
$184,000.00
|
$7.90 M
|
-$2.44 M
|
-$1.81 M
|
-$1.88 M
|
-$1.87 M
|
-$764,000.00
|
$41,000.00
|
| Income Before Tax |
-$15.44 M
|
-$29.31 M
|
-$50.30 M
|
-$23.21 M
|
-$16.44 M
|
-$17.60 M
|
-$16.11 M
|
-$16.14 M
|
-$10.66 M
|
-$6.63 M
|
| Income Before Tax Ratio |
-68.64
|
0
|
-21.11
|
-9.79
|
-10.04
|
-8.72
|
-36.28
|
-40.96
|
-11.24
|
-3.58
|
| Income Tax Expense |
$0.00
|
-$1.64 M
|
$701,000.00
|
$46,000.00
|
$2.47 M
|
-$4,000.00
|
$34,000.00
|
$347,000.00
|
-$65,000.00
|
-$9,000.00
|
| Net Income |
-$24.91 M
|
-$29.31 M
|
-$51.01 M
|
-$23.26 M
|
-$18.92 M
|
-$17.59 M
|
-$16.11 M
|
-$14.53 M
|
-$9.76 M
|
-$6.63 M
|
| Net Income Ratio |
-110.7
|
0
|
-21.4
|
-9.81
|
-11.55
|
-8.72
|
-36.27
|
-36.88
|
-10.3
|
-3.58
|
| EPS |
-6.5 |
-23.94 |
-58.49 |
-29.72 |
-40.26 |
-35.25 |
-18.94 |
-20.38 |
-15.07 |
-11.58 |
| EPS Diluted |
-6.5 |
-23.94 |
-58.49 |
-29.72 |
-40.26 |
-35.25 |
-18.94 |
-20.38 |
-15.07 |
-11.58 |
| Weighted Average Shares Out |
$3.83 M
|
$1.22 M
|
$872,100.00
|
$782,500.00
|
$469,790.00
|
$499,074.00
|
$850,478.00
|
$712,880.00
|
$647,784.00
|
$571,960.00
|
| Weighted Average Shares Out Diluted |
$3.83 M
|
$1.22 M
|
$872,100.00
|
$782,500.00
|
$469,790.00
|
$499,074.00
|
$850,480.00
|
$712,880.00
|
$647,784.00
|
$571,960.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
